Arintra, an Austin, TX–based GenAI-native autonomous medical coding platform for healthcare providers, has raised $21 million in Series A funding.
Investors
The round was led by Peak XV Partners with participation from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and other strategic investors.
Peak XV Partners (formerly Sequoia Capital India & SEA) is a venture capital firm investing across India, Southeast Asia, and beyond. The firm manages over $9 billion in capital across 13 funds and has invested in more than 400 companies.
Arintra Use of Funds
The company will use the funds to accelerate product development, scale its team, expand adoption across U.S. health systems, and open a new Bay Area headquarters.
About Arintra
Founded by Nitesh Shroff and Preeti Bhargava, Arintra is a company that provides a GenAI-powered autonomous medical coding platform, enabling health systems to get paid accurately and efficiently for the care they deliver, driving revenue assurance at scale. Its platform combines large language models with clinical knowledge graphs to interpret patient charts in context and apply specialty-specific coding guidelines with precision. Headquartered in Austin, Texas, Arintra integrates seamlessly with EHR systems like Epic and Athena.
Funding Details
Company: Arintra, Inc.
Raised: $21.0M
Round: Series A
Funding Date: August 2025
Lead Investor: Peak XV Partners
Additional Investors: Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and other strategic investors
Company Website: https://arintra.com/
Software Category: GenAI-powered Autonomous Medical Coding & Revenue Assurance Platform
Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/arintra-raises-21m-series-a-to-expand-beyond-autonomous-medical-codin-1059114